Aisenbrey Elizabeth A, Murphy William L
Department of Surgery, University of Wisconsin-Madison, WI, USA.
Department of Biomedical Engineering, University of Wisconsin-Madison, WI, USA.
Nat Rev Mater. 2020 Jul;5(7):539-551. doi: 10.1038/s41578-020-0199-8. Epub 2020 May 27.
Matrigel, a basement-membrane matrix extracted from Engelbreth-Holm-Swarm mouse sarcomas, has been used for more than four decades for a myriad of cell culture applications. However, Matrigel is limited in its applicability to cellular biology, therapeutic cell manufacturing and drug discovery owing to its complex, ill-defined and variable composition. Variations in the mechanical and biochemical properties within a single batch of Matrigel - and between batches - have led to uncertainty in cell culture experiments and a lack of reproducibility. Moreover, Matrigel is not conducive to physical or biochemical manipulation, making it difficult to fine-tune the matrix to promote intended cell behaviours and achieve specific biological outcomes. Recent advances in synthetic scaffolds have led to the development of xenogenic-free, chemically defined, highly tunable and reproducible alternatives. In this Review, we assess the applications of Matrigel in cell culture, regenerative medicine and organoid assembly, detailing the limitations of Matrigel and highlighting synthetic scaffold alternatives that have shown equivalent or superior results. Additionally, we discuss the hurdles that are limiting a full transition from Matrigel to synthetic scaffolds and provide a brief perspective on the future directions of synthetic scaffolds for cell culture applications.
基质胶是一种从恩格尔布雷特-霍尔姆-斯旺小鼠肉瘤中提取的基底膜基质,四十多年来一直用于众多细胞培养应用。然而,由于其成分复杂、定义不明确且可变,基质胶在细胞生物学、治疗性细胞制造和药物发现中的适用性受到限制。同一批次的基质胶以及不同批次之间的机械和生化特性差异,导致细胞培养实验结果不确定且缺乏可重复性。此外,基质胶不利于物理或生化操作,难以对基质进行微调以促进预期的细胞行为并实现特定的生物学结果。合成支架的最新进展已促成了无动物源、化学成分明确、高度可调且可重复的替代品的开发。在本综述中,我们评估了基质胶在细胞培养、再生医学和类器官组装中的应用,详细阐述了基质胶的局限性,并突出了已显示出同等或更好效果的合成支架替代品。此外,我们讨论了限制从基质胶完全过渡到合成支架的障碍,并简要展望了用于细胞培养应用的合成支架的未来发展方向。